Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcbest (ARCB) Total Liabilities (2016 - 2025)

Arcbest (ARCB) has disclosed Total Liabilities for 17 consecutive years, with $1.2 billion as the latest value for Q4 2025.

  • On a quarterly basis, Total Liabilities rose 3.73% to $1.2 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $1.2 billion, a 3.73% increase, with the full-year FY2025 number at $1.2 billion, up 3.73% from a year prior.
  • Total Liabilities was $1.2 billion for Q4 2025 at Arcbest, down from $1.2 billion in the prior quarter.
  • In the past five years, Total Liabilities ranged from a high of $1.3 billion in Q4 2022 to a low of $916.1 million in Q1 2021.
  • A 5-year average of $1.2 billion and a median of $1.2 billion in 2024 define the central range for Total Liabilities.
  • Peak YoY movement for Total Liabilities: fell 14.79% in 2021, then skyrocketed 33.88% in 2022.
  • Arcbest's Total Liabilities stood at $1.2 billion in 2021, then rose by 13.46% to $1.3 billion in 2022, then decreased by 7.46% to $1.2 billion in 2023, then dropped by 10.25% to $1.1 billion in 2024, then increased by 3.73% to $1.2 billion in 2025.
  • Per Business Quant, the three most recent readings for ARCB's Total Liabilities are $1.2 billion (Q4 2025), $1.2 billion (Q3 2025), and $1.2 billion (Q2 2025).